Mark Rayner is a Managing Partner at Astia, whose known portfolio counts 10 companies.
Is Mark Rayner a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Focus
- BiotechDigital HealthLendingNeobankWealth ManagementWomen-Led
Contacts
Affiliated funds' portfolios
Managing Partner at Astia, whose known portfolio counts 10 companies
- Ellevest
- Goalsetter
- AOA
- Catch+Release
- Mae Health
- CNote
- Pallet
- Aralez Bio
- Repurpose
- Candesant Biomedical
Investor Profile
Mark Rayner is listed against sectors Consumer, FinTech, Healthcare and SaaS, and focus areas Biotech, Digital Health, Lending and Neobank in the database.
Stage-wise, the deals at Astia cluster around Seed, Series A and Series B rounds.
What the affiliated firm has backed is the closest available signal on whether Mark Rayner is worth approaching.
Colleagues at Astia
Sharon Vosmek
CEO
San Francisco, United States
Mary McDougall
Vice President - Access to Growth Capital & Resources
Burlingame, United States
Yashwant Chunduru
Investor
New York, United States
Victoria Pettibone
Chief Investment Officer
New York, United States
Aubrey（Kailin） Song
Angel Investors-Member
Los Angeles, United States
Shufan Lin
Venture Capitalist
London, United Kingdom
Nola E. Masterson
Board of Advisors
San Francisco, United States
Dennis Chan
Member
Menlo Park, United States
Anette Nordvall
Advisor and Early stage Investor
Sweden
Omar Ali
Managing Partner & Fund CFO
San Diego, United States
Mineth Sancho
Angel Investors-Member
Los Angeles, United States
A. Chandra Roxanne
Investor
New Haven, United States
Frequently asked questions
Who is Mark Rayner?
Mark Rayner is a venture capital investor based in Peterborough, England, United Kingdom, listed as Managing Partner at Astia. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Mark Rayner personally.
What does Mark Rayner invest in?
Listed sectors include Consumer, FinTech, Healthcare and SaaS; listed focus areas include Biotech, Digital Health, Lending and Neobank. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Mark Rayner invest at?
Astia appears in Seed, Series A and Series B rounds across its known deals, and Mark Rayner is listed there as Managing Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Mark Rayner listed at?
Mark Rayner is listed as Managing Partner at Astia. 12 other people in the database share a firm with Mark Rayner.
How do I contact Mark Rayner?
An email address, a phone number and a LinkedIn page are on file for Mark Rayner. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal